Skip to main content
×
×
Home

Effects of illness duration and treatment resistance on grey matter abnormalities in majordepression

  • Maria Serra-Blasco (a1), Maria J. Portella (a2), Beatriz Gómez-Ansón (a3), Javier de Diego-Adeliño (a2), Yolanda Vives-Gilabert (a4), Dolors Puigdemont (a2), Ester Granell (a5), Alicia Santos (a6), Enric Álvarez (a7) and Víctor Pérez (a7)...
Abstract
Background

Findings of brain structural changes in major depressive disorder are still inconsistent, partly because some crucial clinical variables have not been taken into account.

Aims

To investigate the effect of major depressive disorder on grey matter volumes.

Method

Voxel-based morphometry was used to compare 66 patients with depression at different illness stages (22 each with first-episode, remitted-recurrent and treatment resistant/chronic depression) with 32 healthy controls. Brain volumes were correlated with clinical variables.

Results

Voxel-based morphometry showed a significant group effect in right superior frontal gyrus, left medial frontal gyrus and left cingulate gyrus (P<0.05, family wise error-corrected). Patients whose condition was treatment resistant/chronic exhibited the smallest volumes in frontotemporal areas. Longer illness duration was negatively correlated with decreases in right medial frontal cortex and left insula.

Conclusions

Frontotemporolimbic areas are smaller in the patients with severe depression and are associated with duration of illness, but not with medication patterns, suggesting negative effects of long-lasting major depressive disorder on grey matter.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Effects of illness duration and treatment resistance on grey matter abnormalities in majordepression
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Effects of illness duration and treatment resistance on grey matter abnormalities in majordepression
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Effects of illness duration and treatment resistance on grey matter abnormalities in majordepression
      Available formats
      ×
Copyright
Corresponding author
Maria J. Portella, Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Institut d'Investigacions Biomédiques de Sant Pau (IIB-Sant Pau); Centro deInvestigación Biomedica en Red de Salud Mental (CIBERSAM), Sant Antoni Ma. Claret 167, 08025 Barcelona, Catalonia, Spain. Email: MPortella@santpau.cat
Footnotes
Hide All

Declaration of interest

V.P. has received educational honoraria from: Sanofi-Aventis, Lundbeck, Pfizer, AstraZeneca and Eli Lilly, and research funding from Boehringer-Ingelheim for this work. E.A. has received consulting and educational honoraria from several pharmaceutical companies including Eli Lilly, Sanofi-Aventis, Lundbeck and Pfizer, and he has participated as main local investigator in clinical trials from Eli Lilly, Bristol-Myers Squibb and Sanofi-Aventis and also as national coordinator of clinical trials from Servier and Lundbeck.

Footnotes
References
Hide All
1 Rubio, JM Markowitz, JC Alegría, A Pérez-Fuentes, G Liu, S-M Lin, K-H et al Epidemiology of chronic and nonchronic major depressive disorder: results from the national epidemiologic survey on alcohol and related conditions. Depress Anxiety 2011; 28: 622–31.
2 Hasler, G. Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatry 2010; 9: 155–61.
3 Du, M-Y Wu, Q-Z Yue, Q Li, J Liao, Y Kuang, W-H et al Voxelwise meta-analysis of gray matter reduction in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2012; 10: 11–6.
4 Bora, E Fornito, A Pantelis, C Yücel, M Gray matter abnormalities in major depressive disorder: a meta-analysis of voxel based morphometry studies. J Affect Disord 2012; 138: 918.
5 Sacher, J Neumann, J Fünfstück, T Soliman, A Villringer, A Schroeter, ML Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. J Affect Disord 2011; 140: 142–8.
6 Kempton, MJ Salvador, Z Munafò, MR Geddes, JR Simmons, A Frangou, S et al Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry 2011; 68: 675–90.
7 Portella, MJ de Diego-Adeliño, J Gómez-Ansón, B Morgan-Ferrando, R Vives, Y Puigdemont, D et al Ventromedial prefrontal spectroscopic abnormalities over the course of depression: a comparison among first episode, remitted recurrent and chronic patients. J Psychiatr Res 2011; 45: 427–34.
8 De Diego-Adeliño, J Portella, MJ Gómez-Ansón, B López-Moruelo, O Serra-Blasco, M Vives, Y et al Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden. J Psychiatry Neurosci 2012; Sept 4 (Epub ahead of print).
9 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn, text revision) (DSM-IV-TR). APA, 2000.
10 Sackeim, HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 2001; 16: 10–7.
11 Thase, ME Rush, AJ. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 1997; 58: 23–9.
12 Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 5662.
13 Ashburner, J Friston, KJ. Unified segmentation. Neuroimage 2005; 26: 839–51.
14 Ashburner, J. A fast diffeomorphic image registration algorithm. Neuroimage 2007; 15: 95113.
15 Fischl, B Sereno, MI Tootell, RB Dale, AM High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum Brain Mapp 1999; 8: 272–84.
16 Dale, AM Fischl, B Sereno, MI Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999; 9: 179–94.
17 Talairach, J Tournoux, P. Co-Planar Stereotaxic Atlas of the Human Brain: An Approach to Medical Cerebral Imaging. Thieme Classics, 1988.
18 Ségonne, F Dale, AM Busa, E Glessner, M Salat, D Hahn, HK et al A hybrid approach to the skull stripping problem in MRI. Neuroimage 2004; 22: 1060–75.
19 Fischl, B Dale, AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 2000; 26: 11050–5.
20 Desikan, RS Ségonne, F Fischl, B Quinn, BT Dickerson, BC Blacker, D et al An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006; 1: 968–80.
21 R Development Core Team. R: A Language and Environment for Statistical Computing. R Development Core Team, 2009 (http://www.R-project.org).
22 Ashburner, J. VBM Tutorial. March 15 2010. UCL, 2010 (http://www.fil.ion.ucl.ac.uk/∼john/misc/VBMclass10.pdf).
23 Mayberg, HS Lozano, AM Voon, V McNeely, HE Seminowicz, D Hamani, C et al Deep brain stimulation for treatment-resistant depression. Neuron 2005; 3: 651–60.
24 Salvadore, G Nugent, AC Lemaitre, H Luckenbaugh, DA Tinsley, R Cannon, DM et al Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder. Neuroimage 2011; 14: 2643–51.
25 Soriano-Mas, C Hernández-Ribas, R Pujol, J Urretavizcaya, M Deus, J Harrison, BJ et al Cross-sectional and longitudinal assessment of structural brain alterations in melancholic depression. Biol Psychiatry 2011; 15: 318–25.
26 Drevets, WC. Neuroplasticity in mood disorders. Dialogues Clin Neurosci 2004; 6: 199216.
27 Gold, PW Drevets, WC Charney, DS New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biol Psychiatry 2002; 1: 381–5.
28 Lim, HK Jung, WS Ahn, KJ Won, WY Hahn, C Lee, SY et al Regional cortical thickness and subcortical volume changes are associated with cognitive impairments in the drug-naive patients with late-onset depression. Neuropsychopharmacology 2012; 37: 838–49.
29 Souery, D Oswald, P Massat, I Bailer, U Bollen, J Demyttenaere, K et al Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry 2007; 68: 1062–70.
30 Arnone, D McKie, S Elliott, R Juhasz, G Thomas, EJ Downey, D et al State-dependent changes in hippocampal grey matter in depression. Mol Psychiatry 2012; Nov 6 (Epub ahead of print).
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The British Journal of Psychiatry
  • ISSN: 0007-1250
  • EISSN: 1472-1465
  • URL: /core/journals/the-british-journal-of-psychiatry
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 2
Total number of PDF views: 25 *
Loading metrics...

Abstract views

Total abstract views: 101 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 12th June 2018. This data will be updated every 24 hours.

Effects of illness duration and treatment resistance on grey matter abnormalities in majordepression

  • Maria Serra-Blasco (a1), Maria J. Portella (a2), Beatriz Gómez-Ansón (a3), Javier de Diego-Adeliño (a2), Yolanda Vives-Gilabert (a4), Dolors Puigdemont (a2), Ester Granell (a5), Alicia Santos (a6), Enric Álvarez (a7) and Víctor Pérez (a7)...
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *